Bruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Go back to Bruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Bruker (BRKR) PT Raised to $29 at Jefferies Following Strong 4Q Results

February 14, 2017 7:25 AM EST

Jefferies analyst Brandon Couillard reiterates Buy rating and raises price target on Bruker Corp. (NASDAQ: BRKR) to $29 (from $28), as the company reported EPS results well above consensus, noting that EU orders turned positive.

Couillard comments, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial... More

Bruker (BRKR) Tops Q4 EPS by 9c, Offers FY Guidance

February 13, 2017 4:11 PM EST

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.46, $0.09 better than the analyst estimate of $0.37. Revenue for the quarter came in at $470.3 million versus the consensus estimate of $464.49 million.

GUIDANCE:

Bruker sees FY2017 EPS of $1.05-$1.09, versus the consensus of $1.10.

For... More